Product
Supplier
Encyclopedia
Inquiry
Capecitabine buy - large image1
Capecitabine buy - image1

Capecitabine

7 Inquiries

Unit Price: Get Latest Price
CAS No.:

154361-50-9

Grade:

Pharmaceutical Grade

Content:

99%

Port:

LIANYUNGANG

Packaging:

25kg/0.2kg Bag

Price valid (until):

2017-05-19

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Capecitabine,Fludarabine,Cisatracurium besylate,Atracurium,4-Chloro-N-methylpicolinamide,Decitabine

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Capecitabine (Capecitabine) is an antimetabolic fluoropyrimidine deoxynucleoside carbamate drug that can be converted to 5-FU in the body. It was developed by Roche under the trade name Xeloda and can inhibit cell division and interference. RNA and protein synthesis. It is suitable for the further treatment of paclitaxel and advanced primary or metastatic breast cancer that does not respond to anthracycline chemotherapy. Mainly used for the treatment of advanced primary or metastatic breast cancer, rectal cancer, colon cancer and gastric cancer.

    Basic Info
    Product Name:

    Capecitabine

    Other Name:

    Cytidine,5′-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-;Carbamic acid,[1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]-,pentyl ester;5′-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine;Ro 09-1978/000;Capecitabine;Ro 09-1978;5′-Deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine;Xeloda;Capecitibine;Capecytabine;Capiibine;Captabin;N4-Pentyloxycarbonyl-5′-deoxy-5-fluorocytidine;Capacetrine;Ecansya;Capecitabine Medac;Capecitabine Accord;Capecitabine Teva;Capecitabine SUN;Xeltabin;158798-73-3;958887-39-3

    CAS No.:

    154361-50-9

    Molecular Formula:

    C15H22FN3O6

    InChIKeys:

    InChIKey=GAGWJHPBXLXJQN-UORFTKCHSA-N

    Molecular Weight:

    359.35000

    Exact Mass:

    359.35

    UNII:

    6804DJ8Z9U

    DSSTox ID:

    DTXSID3046451

    NCI Thesaurus Code:

    C1794

    Color/Form:

    White to off-white crystalline powder|Crystals from ethyl acetate

    ATC Code:

    L01BC06|L - Antineoplastic and immunomodulating agents

    HScode:

    2934999090

    Categories:

    Nucleoside Drugs

    Characteristics
    PSA:

    122.91000

    XLogP3:

    0.6

    Appearance:

    white to beige

    Density:

    1.49 g/cm3

    Melting Point:

    88-89 °C

    Boiling Point:

    437.874ºC at 760 mmHg

    Flash Point:

    218.619ºC

    Refractive Index:

    1.7

    Water Solubility:

    2.48e-01 g/L

    Storage Conditions:

    Store in original container in a cool dark place.

    Vapor Pressure:

    0mmHg at 25°C

    Henrys Law Constant:

    Henry's Law constant = 2.9X10-19 atm-cu m/mol at 25 °C (est)

    Dissociation Constants:

    pKa1 = 1.9 (amide)

    Experimental Properties:

    Hydroxyl radical reaction rate constant = 8.27X10-11 cu cm/molec-sec at 25 °C (est)|Ozone reaction rate constant = 7.0X10-15 cu cm/molec-sec at 25 °C (est)

    Hazard Identification

    Classification of the substance or mixture

    Germ cell mutagenicity, Category 2

    Carcinogenicity, Category 1B

    Reproductive toxicity, Category 1B

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Danger

    Hazard statement(s)

    H341 Suspected of causing genetic defects

    H350 May cause cancer

    H360 May damage fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Capecitabine,Fludarabine,Cisatracurium besylate,Atracurium,4-Chloro-N-methylpicolinamide,Decitabine

    Location:

    Ganyu Economic Development Zone, Liuliqiao Private Industrial Park, No. 406

    Payment Terms:

    D/P,L/C

    Average lead Time:

    60

    Total Annual Revenue:

    Less than $1 million

    Lianyungang Shenghe Biological Technology Co., Ltd. is mainly engaged in the development and production of anti-tumor drug intermediates. The company has complete environmental protection, safety, firefighting procedures, complete public facilities, has relatively complete analysis and testing equipment including liquid chromatograph, gas chromatograph, etc. and has established a relatively complete quality management system. The company has a city-level technology center, a city-level high-tech enterprise, and a green synthesis laboratory jointly established with Jiangsu Marine Resources Research Institute.


    "Technology is the first productive force" and "Technology achieves the future". The company adheres to the strategy of science and technology and talents. At present, the company has 2 PhDs, masters and undergraduates account for more than 60% of the company's staff, and hires several domestic and foreign drug synthesis experts. Guide the company's research and development all the year round, and has established its own characteristics in the research and development of anti-tumor drug intermediates, with many excellent technologies. The company has rich experience in R&D, production, and management, and has developed into a domestic manufacturer and supplier of highly competitive anti-tumor drug intermediates


  • Inquiry History
    7 Inquiries
    Country Product Purchase Quantity Date Posted
    United Arab Emirates

    Capecitabine

    150.00 KG Jul 23, 2024
    Turkey

    Capecitabine

    100 KG Oct 21, 2025
    Japan

    Capecitabine(GMP+CEP)

    100 G May 13, 2024
    Democratic Republic of the Congo

    Capecitabine

    1 MT Dec 8, 2025
    Turkey

    Capcetabine

    100 KG Nov 27, 2025
    Pakistan

    Capecitabine

    1 KG Sep 26, 2025
    Spain

    Capecitabine

    500 MG Oct 23, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.